A detailed history of Prime Capital Investment Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 37,324 shares of ABT stock, worth $4.23 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
37,324
Previous 63,632 41.34%
Holding current value
$4.23 Million
Previous $6.61 Million 35.65%
% of portfolio
0.06%
Previous 0.1%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$100.07 - $118.13 $2.63 Million - $3.11 Million
-26,308 Reduced 41.34%
37,324 $4.26 Million
Q2 2024

Aug 08, 2024

SELL
$100.73 - $112.44 $1.46 Million - $1.63 Million
-14,532 Reduced 18.59%
63,632 $6.61 Million
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $511,786 - $565,246
4,673 Added 6.36%
78,164 $8.88 Million
Q4 2023

Jan 24, 2024

BUY
$90.19 - $110.4 $194,088 - $237,580
2,152 Added 3.02%
73,491 $8.09 Million
Q3 2023

Nov 09, 2023

BUY
$95.53 - $114.62 $694,789 - $833,631
7,273 Added 11.35%
71,339 $6.91 Million
Q2 2023

Aug 08, 2023

BUY
$100.78 - $112.29 $1.19 Million - $1.32 Million
11,796 Added 22.57%
64,066 $6.98 Million
Q1 2023

May 05, 2023

SELL
$96.86 - $114.01 $681,797 - $802,516
-7,039 Reduced 11.87%
52,270 $5.29 Million
Q4 2022

Feb 08, 2023

BUY
$95.06 - $111.52 $1.57 Million - $1.84 Million
16,521 Added 38.61%
59,309 $6.51 Million
Q3 2022

Nov 08, 2022

SELL
$96.76 - $112.03 $355,593 - $411,710
-3,675 Reduced 7.91%
42,788 $4.14 Million
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $2.6 Million - $3.15 Million
25,519 Added 121.84%
46,463 $5.05 Million
Q4 2021

Feb 07, 2022

BUY
$115.53 - $141.46 $662,795 - $811,556
5,737 Added 37.73%
20,944 $2.95 Million
Q3 2021

Nov 09, 2021

BUY
$116.66 - $129.06 $1.46 Million - $1.62 Million
12,531 Added 468.27%
15,207 $1.8 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $74,687 - $87,918
706 Added 35.84%
2,676 $310,000
Q1 2021

May 07, 2021

BUY
$108.84 - $128.23 $107,969 - $127,204
992 Added 101.43%
1,970 $236,000
Q4 2020

Feb 03, 2021

BUY
$105.0 - $114.42 $6,930 - $7,551
66 Added 7.24%
978 $107,000
Q3 2020

Nov 06, 2020

BUY
$91.64 - $111.29 $549 - $667
6 Added 0.66%
912 $99,000
Q2 2020

Jul 17, 2020

SELL
$76.57 - $98.0 $605,592 - $775,082
-7,909 Reduced 89.72%
906 $83,000
Q1 2020

May 04, 2020

SELL
$62.82 - $91.86 $17,840 - $26,088
-284 Reduced 3.12%
8,815 $696,000
Q4 2019

Feb 04, 2020

BUY
$78.51 - $87.4 $25,123 - $27,968
320 Added 3.65%
9,099 $790,000
Q3 2019

Nov 05, 2019

BUY
$81.84 - $88.74 $17,268 - $18,724
211 Added 2.46%
8,779 $735,000
Q2 2019

Aug 06, 2019

BUY
$72.88 - $85.0 $494,709 - $576,980
6,788 Added 381.35%
8,568 $721,000
Q1 2019

Apr 16, 2019

BUY
$66.22 - $80.06 $101,316 - $122,491
1,530 Added 612.0%
1,780 $142,000
Q2 2018

Aug 14, 2018

BUY
$57.57 - $63.54 $14,392 - $15,885
250 New
250 $15,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.